Louise Garrahan, 31 March 2022
A new session on clinical trials has been developed for the Advanced Therapy Medicinal Products elearning programme.
Developed by Health Education England elearning for healthcare (HEE elfh) in partnership with a range of health organisations including the Advanced Therapy Treatment Centre Network and London Advanced Therapies this new session will enable learners to understand key aspects of conducting clinical trials with advanced therapy investigational medicinal products (ATIMPs).
ATIMPs are medicines for human use which are based on genes, tissues or cells that offer ground-breaking new opportunities for the treatment of disease and injury but have not yet received regulatory approval. This new session is designed to provide learners with a refresher of standard clinical trial practices and explains the additional features which impact on the design of trials for ATIMPs.
The new session, which takes approximately 30 minutes to complete, comprises the following topics:
- a general refresher of clinical trial practices
- an overview of the complexities of working with ATIMPs
- additional features which impact on the design of trials for ATIMPs
- specific steps required to initiate trials in ATIMPs
It is primarily aimed at healthcare professionals such as nurses, pharmacists, doctors, who are, or will be, engaged in clinical research with ATIMPs and want to further their understanding of the specifics of undertaking clinical trials with these advanced therapies.
For more information and to access the Clinical Trials resource, please visit the Advanced Therapy Medicinal Products programme page.
Comments are closed.